Editor’s Note: We generally do not include – and certainly do not endorse – any commercial market research content. However, we believe it useful to include information on general vaccine market scaling as an environmental dimension impacting policy, access, pricing and other parameters.
“Global Human Vaccine Industry 2013-2018: Trends, Profits and Forecast Analysis”
Research and Markets (http://www.researchandmarkets.com/research/g6vjj2/global_human)
The global vaccine industry comprises primarily human vaccine production. The annual revenue of this industry is forecast to reach an estimated $41.85 billion by 2018, with good growth over the next five years. Pfizer entered the top five player list in 2012 replacing Wyeth. Sanofi Aventis, Novartis AG, Merck Company, and GlaxoSmithKline are the other players in the top five players list. North America dominates this industry. India and China are rapidly growing as vaccine production hubs with strong domestic demand….